Tacke F - Search Results

1

Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.

Mossanen JC, Krenkel O, Ergen C, Govaere O, Liepelt A, Puengel T, Heymann F, Kalthoff S, Lefebvre E, Eulberg D, Luedde T, Marx G, Strassburg CP, Roskams T, Trautwein C, Tacke F. Mossanen JC, et al. Among authors: tacke f. Hepatology. 2016 Nov;64(5):1667-1682. doi: 10.1002/hep.28682. Epub 2016 Jul 22. Hepatology. 2016. PMID: 27302828

2

Ghrelin in chronic liver disease.

Tacke F, Brabant G, Kruck E, Horn R, Schöffski P, Hecker H, Manns MP, Trautwein C. Tacke F, et al. J Hepatol. 2003 Apr;38(4):447-54. doi: 10.1016/s0168-8278(02)00438-5. J Hepatol. 2003. PMID: 12663236

3

p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.

Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C. Luedde T, et al. Among authors: tacke f. Hepatology. 2003 Apr;37(4):833-41. doi: 10.1053/jhep.2003.50136. Hepatology. 2003. PMID: 12668976

4

[Treatment of hepatitis B and C virus infection].

Trautwein C, Tacke F. Trautwein C, et al. Among authors: tacke f. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S87-9. doi: 10.1055/s-2003-40144. Dtsch Med Wochenschr. 2003. PMID: 12817332 Review. German. No abstract available.

5

Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.

Streetz KL, Tacke F, Leifeld L, Wüstefeld T, Graw A, Klein C, Kamino K, Spengler U, Kreipe H, Kubicka S, Müller W, Manns MP, Trautwein C. Streetz KL, et al. Among authors: tacke f. Hepatology. 2003 Jul;38(1):218-29. doi: 10.1053/jhep.2003.50268. Hepatology. 2003. PMID: 12830005

6

Plasma P-selectin levels are elevated in patients with chronic liver disease.

Tacke F, Schöffski P, Trautwein C, Luedde T, Ganser A, Manns MP, von Depka M. Tacke F, et al. Blood Coagul Fibrinolysis. 2003 Jun;14(4):319-25. doi: 10.1097/00001721-200306000-00001. Blood Coagul Fibrinolysis. 2003. PMID: 12945872

7

Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease.

Tacke F, Schöffski P, Luedde T, Meier PN, Ganser A, Manns MP, Trautwein C. Tacke F, et al. Scand J Gastroenterol. 2004 Mar;39(3):259-66. doi: 10.1080/00365520310008340. Scand J Gastroenterol. 2004. PMID: 15074396

8

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants.

Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C. Tacke F, et al. J Virol. 2004 Aug;78(16):8524-35. doi: 10.1128/JVI.78.16.8524-8535.2004. J Virol. 2004. PMID: 15280461 Free PMC article.

9

Regulation of plasma erythropoietin in chronic liver disease.

Tacke F, Luedde T, Manns MP, Trautwein C. Tacke F, et al. World J Gastroenterol. 2004 Oct 1;10(19):2922-3. doi: 10.3748/wjg.v10.i19.2922. World J Gastroenterol. 2004. PMID: 15334703 Free PMC article. No abstract available.

10

C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.

Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP, Trautwein C. Luedde T, et al. Among authors: tacke f. Hepatology. 2004 Aug;40(2):356-65. doi: 10.1002/hep.20333. Hepatology. 2004. PMID: 15368440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

759 results

Search Page